Partner
All services
ICH-Compliant Stability Programs

Stability Studies Built for Regulatory Confidence.

From pre-clinical development to commercial lifecycle management, Stabicon delivers scientifically structured stability studies designed to support formulation development, regulatory submissions, product quality assurance and market readiness across pharmaceuticals, nutraceuticals, OTC products, herbals, cosmetics, medical devices and FMCG categories.

Our stability programs are conducted under controlled cGMP environments using validated systems and globally aligned protocols to generate reliable, submission-ready data throughout the product lifecycle.

Quick Capability Overview

Stability programs across every development stage.

  • Regulatory Alignment
    ICH, cGMP, Global Stability Guidelines
  • Product Categories
    Pharma, Nutraceuticals, OTC, Cosmetics, Herbals, FMCG
  • Study Support
    Pre-clinical to Phase IV
  • Registration Support
    NDA / MAA Stability Programs
  • Commercial Support
    Marketed Product Stability & PLCM
  • Packaging Support
    Final Pack & Container Closure Evaluation
  • Stability Conditions
    Long-Term, Accelerated, Intermediate
  • Infrastructure
    Controlled Stability Chambers & Monitoring Systems
Comprehensive Stability Studies

Stability testing is one of the most critical components of product development and regulatory compliance.

It establishes how a product maintains its identity, strength, purity, performance and safety over time under the influence of environmental factors such as temperature, humidity and light.

At Stabicon, stability studies are designed not only to meet regulatory expectations, but also to generate actionable scientific understanding around product behavior, degradation kinetics, packaging compatibility and shelf-life optimization.

Our integrated approach combines analytical expertise, formulation understanding, quality systems and regulatory alignment to support organizations through every stage of product development – from early formulation screening to post-approval commercial support.

We support a wide spectrum of dosage forms and product categories while maintaining data integrity, traceability and scientifically robust documentation practices.

Our Stability Study Services

Seven program tracks – one continuous scientific story.

Pre-clinical stability studies are initiated during the early development phase to support toxicological studies and initial formulation feasibility.

These studies help evaluate

  • API stability characteristics
  • Drug-excipient compatibility
  • Early degradation pathways
  • Preliminary packaging suitability
  • Storage condition feasibility

Applications

Animal toxicology supportPrototype formulation screeningPre-formulation studiesEarly analytical evaluation

Phase I studies focus on establishing the stability profile of investigational products intended for initial human trials.

These studies are designed to

  • Support formulation optimization
  • Establish API compatibility within the formulation
  • Ensure stability of Clinical Trial Materials (CTM)
  • Generate early-stage storage recommendations

Key Focus Areas

Drug-excipient interaction studiesCTM stability evaluationInitial shelf-life estimationPackaging compatibility studies

Stability studies during Phase II and III clinical trials are essential to support expanding clinical programs and validate formulation robustness under intended storage conditions.

Stabicon conducts scientifically designed studies on

  • Drug substances
  • Drug products
  • Comparator products
  • Clinical trial batches

Deliverables

Stability trend analysisDegradation profilingOngoing analytical supportShelf-life data generationRegulatory-ready documentation

These programs provide the scientific basis for establishing product specifications, recommended storage conditions, final shelf-life assignment and commercial packaging validation. Our studies are structured to understand degradation kinetics and long-term product behavior under multiple environmental conditions.

Programs establish

  • Product specifications
  • Recommended storage conditions
  • Final shelf-life assignment
  • Commercial packaging validation

Includes

Accelerated stability studiesLong-term stability studiesIntermediate condition studiesPackaging interaction evaluationShelf-life modeling

Registration stability studies are conducted on scale-up batches, process validation batches, registration batches and final commercial packaging configurations.

Programs support regulatory submissions for

  • NDA filings
  • MAA filings
  • International dossier submissions
  • Market authorization requirements

Stabicon Supports

Protocol designStability sample managementTesting executionTrend analysisRegulatory documentationStability summaries for submissions

Phase IV and marketed product stability programs ensure that commercial products continue to meet quality specifications throughout their market lifecycle.

These studies support

  • Ongoing quality assurance
  • Batch monitoring
  • Shelf-life confirmation
  • Commercial compliance

Applications

Annual stability commitmentsRetention sample evaluationCommercial quality controlMarket surveillance support

Stability studies play a critical role in supporting modifications made after product approval.

Stabicon supports

  • Scale-Up and Post Approval Changes (SUPAC)
  • Packaging modifications
  • Manufacturing site transfers
  • Process optimization
  • New dosage form introductions
  • Product lifecycle management initiatives

Areas Covered

Bridging stability studiesComparative stability evaluationPackaging migration studiesReformulation supportExtended shelf-life evaluation
Products & Industries We Support

Broad category expertise. Deep dosage-form fluency..

Product Categories

PharmaceuticalsNutraceuticalsOTC ProductsHerbal FormulationsCosmeticsMedical DevicesFMCG Products

Dosage Forms

TabletsCapsulesPowdersLiquidsSachetsGummiesSemi-solidsSuspensionsEffervescent systems
Stability Infrastructure & Scientific Capabilities

Controlled stability environments designed for data integrity.

Stabicon operates stability facilities designed to maintain controlled environmental conditions with continuous monitoring systems aligned to global quality expectations.

Infrastructure Highlights

  • cGMP-compliant operations
  • Controlled stability chambers
  • Long-term, accelerated & intermediate storage conditions
  • Continuous environmental monitoring
  • Qualified storage systems
  • Data traceability & documentation systems

Analytical Integration

Our stability programs are fully supported by integrated:

  • Analytical Research & Development
  • Method Validation
  • Quality Control
  • Microbial Testing capabilities

This allows seamless execution from study initiation through final reporting.

Regulatory & Quality Compliance

Quality systems designed around global standards.

Every stability program at Stabicon is executed within a structured quality framework designed to support audit readiness, regulatory reliability and scientific reproducibility.

Compliance Standards

  • ICH Guidelines
  • cGMP Practices
  • SOP-Driven Operations
  • Data Integrity Compliance
  • Validated Analytical Methods
  • Documentation Traceability

Documentation Support

  • Stability protocols
  • Stability summaries
  • Trend reports
  • COAs
  • Regulatory submission support
  • Investigation reports
Our Stability Workflow

A structured approach to stability management.

01

Technical Assessment

Understanding product profile, dosage form, packaging and regulatory requirements.

02

Protocol Design

Designing scientifically aligned stability protocols and testing schedules.

03

Sample Storage & Monitoring

Controlled placement within validated stability environments.

04

Analytical Testing

Scheduled testing using validated analytical methodologies.

05

Data Evaluation & Trending

Assessment of degradation behavior and stability trends.

06

Reporting & Regulatory Support

Generation of submission-ready documentation and final recommendations.

    01 / 06
    Why Stabicon

    Stability expertise backed by scientific integration.

    01

    End-to-End Lifecycle Support

    From early development through commercialization and lifecycle management.

    02

    Multi-Category Experience

    Expertise across pharmaceuticals, nutraceuticals, herbals, OTC, cosmetics and FMCG products.

    03

    Integrated Scientific Capabilities

    Stability studies supported by analytical, microbial, formulation and quality control teams.

    04

    Regulatory Understanding

    Programs aligned to global regulatory expectations and documentation standards.

    05

    Flexible Development Support

    Support for innovator, generic, nutraceutical and market-specific products.

    06

    Commercially Relevant Execution

    Designed to support speed, scalability, compliance and market readiness.

    Case Snapshots

    Real programs..

    Case 01

    Nutraceutical Moisture-Sensitive Product

    Challenge

    A hygroscopic nutraceutical formulation demonstrated rapid degradation under elevated humidity conditions.

    Solution

    Stabicon designed accelerated and intermediate stability studies with comparative packaging evaluations.

    Outcome

    Optimized packaging selection and improved projected shelf-life performance.

    Case 02

    OTC Product Scale-Up Stability Support

    Challenge

    A client required stability support during commercial scale-up and packaging transition.

    Solution

    SUPAC-aligned comparative stability program with analytical trending support.

    Outcome

    Successful scale-up validation with continuity in product performance.

    Frequently Asked Questions

    Common stability questions.

    We support long-term, accelerated and intermediate stability studies under controlled environmental conditions aligned with applicable regulatory guidelines.

    Yes. We support pharmaceuticals, nutraceuticals, herbals, OTC products, cosmetics, medical devices and FMCG categories.

    Yes. We conduct registration stability studies and provide supporting documentation for NDA, MAA and international submissions.

    Yes. We conduct SUPAC and PLCM stability studies for packaging changes, process changes, reformulations and scale-up activities.

    Yes. Our integrated scientific infrastructure allows seamless coordination across analytical development, microbial analysis, quality control and stability testing.
    Stability Programs

    Designed for product confidence at every stage.

    Whether you are developing a new formulation, preparing for regulatory submission, scaling manufacturing or managing commercial product quality, Stabicon delivers scientifically structured stability studies aligned to your development and compliance goals.

    Stabicon Life Sciences

    Science-Led Formulations. Scalable Health Platforms.

    Offices

    Corporate Office

    22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

    Research & Development

    28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

    Newsletter

    Quarterly briefings on platforms, science & partnerships.

    No spam. Unsubscribe in one click. Your email stays with us.

    Press Kit

    Logos, company information & spokesperson details – available from our media team.

    Request Press Kit

    For media queries: press@stabicon.com

    Accreditations

    ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

    Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

    © 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

    Science-Led Formulations. Scalable Health Platforms.

    Admin